about the author

Josh Sullivan

josh@endpointsnews.com

author articles

With the ground bro­ken on a Van­cou­ver head­quar­ters, an­ti­body mak­er Ab­Cellera will add man­u­fac­tur­ing space next door

4 years ago
Manufacturing

Emer­gen­t's bad year con­tin­ues with House over­sight com­mit­tee de­mand­ing doc­u­ments tied to vac­cine screwup

4 years ago
Manufacturing

J&J, Leg­end un­veil plans for Bel­gian cell ther­a­py man­u­fac­tur­ing fa­cil­i­ty as the part­ners await ap­proval for lead drug

4 years ago
Manufacturing

A French CD­MO looks to add even more cell and gene ther­a­py ca­pac­i­ty at a Paris-area site

4 years ago
Outsourcing
Manufacturing

Q&A: When the pan­dem­ic struck, Catal­en­t's CCO had just joined the team

4 years ago
People
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Smug­gled remde­sivir seized en route to Mex­i­co; As Sput­nik awaits WHO ap­proval, a ...

4 years ago
Outsourcing
Manufacturing

Hutchmed/As­traZeneca lung can­cer drug gets OK in Chi­na; Enan­ta re­ports PhIb da­ta for their oral he­pati­tis B pro­gram

4 years ago
News Briefing

Gala­pa­gos CSO hits the ex­it as the biotech looks to pick up the pieces af­ter FDA's fil­go­tinib re­jec­tion

4 years ago
People

Roche's Alzheimer's drug spurred bio­mark­er changes but no cog­ni­tive im­pact — pa­per; vTv out-li­cens­es for­mer lead ...

4 years ago
News Briefing

Covid-19 roundup: White House re­veals vac­cine do­na­tion plan; EU opts in for an­oth­er 150 mil­lion dos­es from Mod­er­na

4 years ago
Coronavirus

Al­fasig­ma snares EU rights to blood clot­ting an­ti­body on the hunt for pa­tients tak­ing As­traZeneca's Bril­in­ta

4 years ago
Deals

South African con­sor­tium es­tab­lish­es mR­NA tech trans­fer hub to get vac­cines to a re­gion of­ten over­looked

4 years ago
Coronavirus
Manufacturing

South Ko­re­an vac­cine mak­er pumps up its pro­duc­tion ca­pac­i­ty as Covid-19 de­mand holds steady

4 years ago
Coronavirus
Manufacturing

Covid-19 roundup: Af­ter win­ning an EUA, GSK and Vir are back with full da­ta on their mon­o­clon­al an­ti­body; New Zealand ...

4 years ago
Coronavirus

Jim Green­wood opens new pol­i­cy shop, with an eye on drug price con­trols; Mod­er­na, CRISPR, Mus­tang re­ceive tax breaks ...

4 years ago
News Briefing

Covid-19 roundup: Both As­traZeneca and EC claim a win in le­gal case over vac­cine de­lay; South Ko­rea to mix-and-match ...

4 years ago
Coronavirus

In an ef­fort to safe­ly de­liv­er mR­NA, Stan­ford Uni­ver­si­ty teams up with Ger­man biotech Evonik

4 years ago
Deals
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: As the US gov­ern­ment bags an­oth­er 100M dos­es of Mod­er­na shot, the biotech is chip­ping ...

4 years ago
Coronavirus
Manufacturing

In a move to boost its nat­ur­al killer can­di­dates, Sen­ti Bio will build out its own San Fran­cis­co man­u­fac­tur­ing ...

4 years ago
Cell/Gene Tx
Manufacturing

Vi­ral man­u­fac­tur­er Viba­log­ics plots out ex­pan­sion at Ger­man site as US growth plans are un­der­way

4 years ago
Outsourcing
Manufacturing

Sid Mukher­jee's Vor adds clin­i­cal man­u­fac­tur­ing fa­cil­i­ty at ex­ist­ing Boston-area site, beef­ing up for a com­mer­cial ...

4 years ago
R&D
Manufacturing

No­vo Nordisk to re­search oral obe­si­ty treat­ment; Dana-Far­ber taps in­to Har­bour Bio­Med's mice plat­form in mul­ti­year ...

4 years ago
News Briefing

A UK biotech looks to up­set the pre­clin­i­cal mod­el for liv­er drug de­vel­op­ment, and now it's gear­ing up for the clin­ic

4 years ago
Financing

Covid-19 roundup: Re­al world da­ta sug­gest As­traZeneca vac­cine ef­fec­tive against Delta, Al­pha vari­ants; No­vavax hails ...

4 years ago
Coronavirus
First page Previous page 19202122232425 Next page Last page
A service from the Financial Times